Impact of the COVID-19 Pandemic on Gyne-Oncological Treatment-A Retrospective Single-Center Analysis of a German University Hospital with 30,525 Patients.

COVID-19 gyne-oncology maximum service supplier pandemic university hospital

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
28 Nov 2022
Historique:
received: 31 10 2022
revised: 23 11 2022
accepted: 25 11 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 24 12 2022
Statut: epublish

Résumé

The study pursues the objective of drawing a comparison between the data of gyne-oncology, gynecology, and obstetrics patient collectives of a German university hospital regarding the progression of patient number and corresponding treatment data during the five-year period of 2017-2021 to assess the impact of the COVID-19 pandemic on gyne-oncological treatment. Descriptive assessment is based on data extracted from the database of the hospital controlling system QlikView

Identifiants

pubmed: 36553910
pii: healthcare10122386
doi: 10.3390/healthcare10122386
pmc: PMC9777581
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Gynecol Oncol. 2022 May;165(2):330-338
pubmed: 35221132
Eur J Obstet Gynecol Reprod Biol. 2020 Dec;255:172-176
pubmed: 33142263
Am J Emerg Med. 2021 Aug;46:382-391
pubmed: 33268238
Int J Infect Dis. 2022 May;118:150-154
pubmed: 35235826
J Clin Med. 2022 Apr 27;11(9):
pubmed: 35566576
Rev Med Virol. 2022 Jul;32(4):e2318
pubmed: 34921468
Int J Environ Res Public Health. 2020 Dec 14;17(24):
pubmed: 33327486
Lancet. 2021 Jan 2;397(10268):61-67
pubmed: 33275906
Cochrane Database Syst Rev. 2021 Mar 11;3:CD013879
pubmed: 33704775
Cancers (Basel). 2021 Jan 22;13(3):
pubmed: 33499223
In Vivo. 2013 Nov-Dec;27(6):855-67
pubmed: 24292593
Curr Treat Options Oncol. 2021 Nov 23;22(12):117
pubmed: 34812973
Gynecol Oncol. 2020 Nov;159(2):470-475
pubmed: 32981694
J Obstet Gynaecol Res. 2021 May;47(5):1643-1650
pubmed: 33650217
Front Surg. 2022 Aug 23;9:883935
pubmed: 36081587
Medicina (Kaunas). 2022 Sep 01;58(9):
pubmed: 36143880
Nat Med. 2021 Jun;27(6):964-980
pubmed: 34002090
Cancers (Basel). 2022 Sep 05;14(17):
pubmed: 36077872
Science. 2022 May 6;376(6593):eabn4947
pubmed: 35289632
MedComm (2020). 2021 Oct 19;2(4):846-854
pubmed: 34909755
Heart Fail Rev. 2022 Jan;27(1):251-261
pubmed: 33761041
Medicina (Kaunas). 2022 Sep 21;58(10):
pubmed: 36295483
Sci Rep. 2022 Jun 2;12(1):9236
pubmed: 35654940
Lancet Reg Health Eur. 2021 Oct;9:100188
pubmed: 34514453
J Cancer Res Clin Oncol. 2022 Nov;148(11):3117-3123
pubmed: 35041059
Geburtshilfe Frauenheilkd. 2022 Apr 05;82(4):427-440
pubmed: 35392066
Med Decis Making. 2021 May;41(4):379-385
pubmed: 33535889
J Minim Invasive Gynecol. 2021 Jul;28(7):1411-1419.e1
pubmed: 33248312
Healthcare (Basel). 2022 Nov 21;10(11):
pubmed: 36421653
Radiology. 2021 Feb;298(2):E70-E80
pubmed: 33320063
J Perinat Med. 2020 Nov 26;48(9):997-1000
pubmed: 32628638
Viruses. 2022 Jan 30;14(2):
pubmed: 35215887

Auteurs

Sebastian Griewing (S)

Department of Gynecology and Obstetrics, University Hospital Marburg, Philipps-University Marburg, Baldingerstraße, 35043 Marburg, Germany.
Institute for Healthcare Management, Chair of General Business Administration, Philipps-University Marburg, Universitätsstraße 24, 35037 Marburg, Germany.

Matthias Kalder (M)

Department of Gynecology and Obstetrics, University Hospital Marburg, Philipps-University Marburg, Baldingerstraße, 35043 Marburg, Germany.

Michael Lingenfelder (M)

Institute for Healthcare Management, Chair of General Business Administration, Philipps-University Marburg, Universitätsstraße 24, 35037 Marburg, Germany.

Uwe Wagner (U)

Department of Gynecology and Obstetrics, University Hospital Marburg, Philipps-University Marburg, Baldingerstraße, 35043 Marburg, Germany.

Niklas Gremke (N)

Department of Gynecology and Obstetrics, University Hospital Marburg, Philipps-University Marburg, Baldingerstraße, 35043 Marburg, Germany.

Classifications MeSH